drugset / Trial / NCT04105504

Oral Glutathione As A Skin Whitening Agent

NCT04105504

Phase 1 Completed 90 enrolled Dr Irma Bernadette S Sitohang
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of the study was to evaluate the efficacy and safety of oral glutathione for 12 weeks, used as a skin-whitening agent. The study was a randomized, double-blind, placebo-controlled, multicenter study, set at Dermatology outpatient clinic at three different hospitals in Indonesia, Gatot Seobroto Army Hospital Jakarta, Dr. dr. Wahiddin Soedirohoesodo Hospital Makassar, and University of Sumatera Utara Teaching Hospital Medan. Ninety healthy females, aged between 33 and 50 years, were randomized to receive either glutathione capsules or placebo for 12 weeks and evaluated every 4 weeks. The main outcome was total reduction (improvement) of spot UV, spot polarization, and skin tone measured at five different sites for each indices, recorded by Janus Facial Analysis System®.

Timeline

Start
2018-04-08
Primary completion
2018-06-06
Completion
2018-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Glutathione Peptide 500 mg Oral